NewGenIvf Group Ltd (NASDAQ:NIVF) shares gained 28.51% to $0.13 in after-hours trading on Thursday after announcing that the diversified healthcare and technology-driven platform announced that it closed a reasonable best efforts public offering with gross proceeds of about $1.25 million.
Offering Details
The amount is before placement agent fees and other offering expenses, according to the company.
The offering totaled 17.85 million Class A Ordinary Shares or pre-funded warrants. It included 125,000 shares and warrants for up to 17.73 million shares.
The price was $0.07 per share and $0.06999 per pre-funded warrant. The warrants are immediately exercisable.
New York-based investment banking firm Aegis Capital Corp. was the exclusive placement agent.
Trading Metrics, Technical Analysis
NewGenIvf Group has a market capitalization of approximately $209,870. Its stock has traded between a 52-week high of $1,539 and a 52-week low of $0.06.
NIVF has a Relative Strength Index (RSI) of 19.83.
Over the past 12 months, the small-cap stock has fallen 99.99%.
Price Action: In the regular session, NIVF stock closed at $0.10, down 39.88%, according to Benzinga Pro data.
Benzinga’s Edge Stock Rankings indicate that NewGenIvf stock has a negative price trend across all time frames.
See More: Top Value Stocks
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Ksw Photographer on Shutterstock.com
Login to comment